Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
GENTA INC DE (GNTA)
|
Add to portfolio |
|
|
|
| Price: |
$10.88
| | Metrics |
| OS: |
2.45
|
B
| |
|
|
| Market cap: |
$26.7
|
B
| |
|
|
|
Net cash:
|
$2.34
|
M
| |
$0.00
|
per share
|
|
EV:
|
$26.7
|
B
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($126)
|
M
| |
|
|
|
EBIT
|
($126)
|
M
| |
|
|
| EPS |
($0.15)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-11 | Dec-31-10 | Dec-31-09 | Dec-31-08 | Dec-31-07 | Dec-31-06 | Dec-31-05 | Dec-31-04 |
| Revenues | 0.2 | 0.3 | 0.2 | 0.4 | 0.6 | 0.7 | 26.6 | 14.6 |
| Revenue growth | -24.5% | 17.9% | -39.9% | -37.4% | -18.1% | -97.3% | 81.9% | 119.5% |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 1.5 |
| Gross profit | 0.2 | 0.2 | 0.2 | 0.3 | 0.5 | 0.6 | 26.5 | 13.1 |
| Gross margin | 96.4% | 81.7% | 81.7% | 71.9% | 84.5% | 84.7% | 99.8% | 89.6% |
| Selling, general and administrative | 6.3 | 9.8 | 17.2 | 10.5 | 16.9 | 25.2 | 16.1 | 28.6 |
| Research and development | 12.4 | 10.0 | 15.1 | 20.0 | 13.5 | 28.1 | 20.9 | 71.5 |
| EBIT | -126.8 | -320.0 | -88.0 | -509.3 | -24.0 | -56.5 | -0.8 | -32.5 |
| EBIT margin | -65341.2% | -124496.5% | -40359.2% | -140297.2% | -4129.8% | -7979.4% | -2.9% | -222.5% |
| Pre-tax income | -70.6 | -167.8 | -89.2 | -507.8 | -24.8 | -57.7 | -2.6 | -33.6 |
| Income taxes | 1.2 | 0.5 | -2.9 | -2.0 | -1.5 | -0.9 | -0.4 | -0.9 |
| Tax rate | | | 3.2% | 0.4% | 5.9% | 1.6% | 14.7% | 2.7% |
| Net income | -69.4 | -167.3 | -86.3 | -505.8 | -23.3 | -56.8 | -2.2 | -32.7 |
| Net margin | -35783.5% | -65096.9% | -39587.6% | -139349.3% | -4020.7% | -8019.9% | -8.3% | -223.6% |
| |
| Diluted EPS | ($0.20) | ($246.04) | ($4,109.57) | ($455.09) | ($0.79) | ($2.52) | ($0.13) | ($0.41) |
| Shares outstanding (diluted) | 347.1 | 0.7 | 0.0 | 1.1 | 29.5 | 22.5 | 16.9 | 79.8 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|